RLAY
Relay Therapeutics, Inc.Open17.37−0.61 −3.39%USD
NasdaqGM · as of Oct 13, 15:51 ET · 15m delay
Open
17.84
Prev close
17.98
Day range
17.2717.94
52-week range
5.8521.27
Volume
1.02M0.37×
Mkt cap
3.81B
P/E ttm
—
Fwd P/E
-10.64
EPS ttm
-1.56
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−18.34%
RLAY shareholders
RLAY Ownership
13F / N-PORT filings via Yahoo
Institutions
110.9%
112.6% of the float
Insiders
1.6%
officers and directors
Institutional holders
349
filing positions
Top 10 institutions
63.5%
8 adding · 1 trimming
Top Institutions
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| SB Investment Advisers (UK) LTD | 12.73% | 27.90M | $484.71M | 0.0% | Jun 30, 2026 |
| FMR, LLC | 9.18% | 20.11M | $349.31M | +444.2% | Jun 30, 2026 |
| Casdin Capital, LLC | 7.32% | 16.04M | $278.53M | +11.2% | Jun 30, 2026 |
| Blackrock Inc. | 6.98% | 15.29M | $265.56M | +17.8% | Jun 30, 2026 |
| Perceptive Advisors Llc | 6.44% | 14.11M | $245.02M | +44.7% | Jun 30, 2026 |
| Commodore Capital Lp | 5.48% | 12.00M | $208.44M | −29.4% | Jun 30, 2026 |
| State Street Corporation | 4.62% | 10.13M | $175.88M | +62.4% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 4.09% | 8.96M | $155.71M | +21.4% | Jun 30, 2026 |
| Price (T.Rowe) Associates Inc | 3.52% | 7.71M | $133.90M | +300.5% | Jun 30, 2026 |
| Nextech Invest, Ltd. | 3.09% | 6.78M | $117.71M | +22.6% | Jun 30, 2026 |
Top Funds
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.10% | 6.80M | $118.12M | +18.6% | Jun 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.03% | 6.64M | $115.40M | +7.6% | Aug 31, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.89% | 4.15M | $72.12M | +0.7% | Aug 31, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 0.95% | 2.08M | $36.13M | 0.0% | Aug 31, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.89% | 1.94M | $33.76M | +32.4% | Jun 30, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 0.89% | 1.94M | $33.77M | +0.9% | Aug 31, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 0.88% | 1.92M | $33.31M | +14.1% | Jul 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.84% | 1.84M | $31.98M | +41.6% | Jun 30, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 0.84% | 1.85M | $32.15M | 0.0% | Aug 31, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.81% | 1.77M | $30.71M | +0.9% | Jul 31, 2026 |
Institutions report quarterly, up to 45 days after the quarter ends, so these positions can be months old. Change compares the share count with the holder's previous filing. Insider transactions are on the overview page (INSD).